Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline

Affiliations

• ¹ Department of guideline development and research, Dutch College of General Practitioners, Utrecht, The Netherlands t.kuijpers@nhg.org.
• ² McMaster University, Hamilton, Canada.
• ³ Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada L8S 4L8.
• ⁴ Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
• ⁵ Norwegian Institute of Public Health, Oslo, Norway.
• ⁶ Department of Medicine, Innlandet Hospital Trust - division Gjøvik, Norway.
• ⁷ University of Washington, Seattle, District of Colombia, USA.
• ⁸ Division of Neurology, Department of Medicine, Queen's University, Kingston, Ontario, Canada.
• ⁹ University of California Davis, Sacramento, CA, USA.
• ¹⁰ All India Institute of Medical Sciences, New Delhi, India.
• ¹¹ University Medical Center of Groningen, Groningen, The Netherlands.
• ¹² Departments of Anesthesia & Perioperative Medicine, and Epidemiology & Biostatistics, Western University, London, Canada.
• ¹³ Division General Internal Medicine, University Hospitals of Geneva, CH-1211, Geneva, Switzerland.
• ¹⁴ NUI Galway, Galway, Ireland.
• ¹⁵ Oslo University Hospital, Oslo, Norway.
• ¹⁶ Las Vegas, Nevada, USA.
• ¹⁷ Boulder, Colorado, USA.
• ¹⁸ Welwyn, Hertfordshire, UK.
• ¹⁹ Division General Internal Medicine & Division of Clinical Epidemiology, University Hospitals of Geneva, CH-1211, Geneva, Switzerland.